The company and its board of directors ensure that the information contained herein is true, accurate, and complete, without any false records, misleading statements, or major omissions.
Sunflower Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") held its 21st meeting of the 5th Board of Directors on April 21, 2026, where it was resolved to deregister the subsidiary Sunflower Pharmaceutical Co., Ltd. (hereinafter referred to as "the Subsidiary"). The Company will handle the deregistration process in accordance with relevant laws and regulations.